Dennis KIRCHHOFF

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted aminoquinolones as DGKalpha inhibitors for immune activ...
- Patent number 11,998,539
- Issue date Jun 4, 2024
- Bayer Aktiengesellschaft
- Norbert Schmees
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminothiazoles as DGKzeta inhibitors for immune activation
- Patent number 11,964,953
- Issue date Apr 23, 2024
- Bayer Aktiengesellschaft
- Norbert Schmees
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
- Patent number 11,660,351
- Issue date May 30, 2023
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,643,469
- Issue date May 9, 2023
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADCS) having enzymatically cleavable groups
- Patent number 11,478,554
- Issue date Oct 25, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody drug conjugates (ADCs) having KSP inhibitors
- Patent number 11,433,140
- Issue date Sep 6, 2022
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...
- Patent number 11,001,636
- Issue date May 11, 2021
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...
- Patent number 10,744,205
- Issue date Aug 18, 2020
- Bayer Pharma Aktiengesellschaft
- Hans-Georg Lerchen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20230399411
- Publication date Dec 14, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20230338559
- Publication date Oct 26, 2023
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230167078
- Publication date Jun 1, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230167103
- Publication date Jun 1, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230148194
- Publication date May 11, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION
- Publication number 20230139936
- Publication date May 4, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...
- Publication number 20230064809
- Publication date Mar 2, 2023
- Bayer Aktiengesellschaft
- Norbert SCHMEES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20220362392
- Publication date Nov 17, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20220267457
- Publication date Aug 25, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20220016258
- Publication date Jan 20, 2022
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20210230284
- Publication date Jul 29, 2021
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
- Publication number 20190365916
- Publication date Dec 5, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
- Publication number 20190328897
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...
- Publication number 20190330357
- Publication date Oct 31, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...
- Publication number 20180318437
- Publication date Nov 8, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Hans-Georg LERCHEN
- C07 - ORGANIC CHEMISTRY

Dennis KIRCHHOFF

Person

Patents Grantslast 30 patents

Substituted aminoquinolones as DGKalpha inhibitors for immune activ...

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

Antibody drug conjugates (ADCs) having enzymatically cleavable groups

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

Specific antibody drug conjugates (ADCs) having KSP inhibitors

Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and an...

Antibody drug conjugates of kinesin spindel protein (KSP) inhibitor...

Patents Applicationslast 30 patents

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIV...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND AN...

ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITOR...